Case Details
- Citation: [2012] SGHC 191
- Title: Low Chai Ling v Singapore Medical Council
- Court: High Court of the Republic of Singapore
- Date of Decision: 17 September 2012
- Case Number: Originating Summons No 18 of 2012
- Coram: Chan Sek Keong CJ; Andrew Phang Boon Leong JA; V K Rajah JA
- Judgment Author: V K Rajah JA (delivering the judgment of the court)
- Applicant/Respondent: Low Chai Ling (applicant) v Singapore Medical Council (respondent)
- Procedural History: Appeal against the decision of the disciplinary committee (“DC”) constituted by the Singapore Medical Council (“SMC”)
- Legal Area: Medical profession and practice; professional conduct; disciplinary proceedings
- Key Statutory Provision Referenced (as stated in extract): s 45(1)(d) of the Medical Registration Act (Cap 174, 1998 Rev Ed) (“MRA (1998)”)—professional misconduct
- Ethical Code Provision Referenced (as stated in extract): Art 4.1.4 of the SMC’s Ethical Code and Ethical Guidelines (“ECEG”)—untested practices and clinical trials
- Counsel for Applicant: Myint Soe and Daniel Atticus Xu (MyintSoe & Selvaraj)
- Counsel for Respondent: Tan Chee Meng SC, Josephine Choo and Maxine Ung (WongPartnership LLP)
- Judgment Length: 29 pages, 14,961 words
- Cases Cited: [2012] SGHC 191 (as provided in metadata)
Summary
Low Chai Ling v Singapore Medical Council concerned disciplinary action against a general practitioner, Dr Low Chai Ling, arising from her promotion and provision of certain aesthetic procedures. The SMC’s disciplinary committee (“DC”) found that Dr Low had offered and performed five out of seven charges of aesthetic procedures that were not clinically justifiable. Dr Low appealed to the High Court, challenging the DC’s findings and the conclusion that her conduct amounted to professional misconduct under the Medical Registration Act (Cap 174, 1998 Rev Ed) (“MRA (1998)”).
The High Court (per V K Rajah JA) upheld the DC’s decision. The court’s analysis focused on whether the procedures were “generally accepted” by the medical profession and whether Dr Low’s conduct complied with the ethical framework governing untested practices and clinical trials. The court accepted that the relevant ethical standard, particularly Art 4.1.4 of the SMC’s Ethical Code and Ethical Guidelines (“ECEG”), required more than mere assertions of peer usage or the existence of some literature; it required that the doctor’s proposed treatment approach be clinically justifiable and appropriately framed within accepted medical practice or a properly approved clinical trial.
What Were the Facts of This Case?
Dr Low was a general practitioner who obtained her MBBS in 1998 and later completed a Diploma of Dermatology in 2003. She operated a GP clinic from 2000 and subsequently established The Sloane Clinic in 2003, with a second branch in 2005. By the material time in 2007, she was the director of The Sloane Clinic, which offered both non-invasive aesthetic treatments and invasive plastic surgery. Importantly, the factual matrix in the extract indicates that Dr Low herself performed non-invasive aesthetic treatments such as lasers, filler and botox, while accredited plastic surgeons performed invasive cosmetic and reconstructive surgery.
In 2007, the Ministry of Health (“MOH”) wrote to Dr Low regarding certain advertisements on the clinic’s website. The MOH identified a list of aesthetic treatments being offered online, including mesotherapy, mesoglow, mesolift, meso-oxygen, stem cell extract facial therapy, stem cell extract scalp therapy, sonophoresis, carboxytherapy and osmolipolysis. The MOH’s letter directed Dr Low’s attention to Art 4.1.4 of the ECEG, which addresses “Untested practices and clinical trials”. The ethical provision emphasises that doctors should treat patients according to generally accepted methods and use only licensed drugs for appropriate indications, and it prohibits offering remedies not generally accepted by the profession except within a formal and approved clinical trial.
Dr Low responded by stating that the clinic had removed the listed services from sections of its website. However, the MOH later requested detailed descriptions of how Dr Low carried out nine specific procedures. Dr Low then provided descriptions and asserted that the procedures were “accepted by the general profession” based on the fact that other clinics and hospitals offered them. She also provided lists of other websites offering similar treatments and expressed concern that the MOH’s investigation might be less than transparent, suggesting it could be driven by professional jealousy or competition.
After these exchanges, a newspaper article titled “SKIN FLICK” was published in The Straits Times on 15 November 2007, introducing aesthetic procedures that purportedly revitalised skin without surgery. Dr Low was interviewed in connection with stem cell mesotherapy for hair loss and skin pigmentation. The MOH subsequently issued an official complaint to the SMC on the same day, stating that Dr Low had not removed the items from the clinic’s website during the inquiry and that the newspaper article suggested she was still providing stem cell injections for aesthetic indications. The MOH’s complaint expressed concern that Dr Low may have breached Art 4.1.4 of the ECEG.
What Were the Key Legal Issues?
The central legal issue was whether Dr Low’s conduct in offering and performing the relevant aesthetic procedures amounted to professional misconduct under s 45(1)(d) of the MRA (1998). In disciplinary proceedings, the question is not merely whether a practitioner deviated from a preferred medical approach, but whether the practitioner’s conduct fell below the standard expected of registered medical practitioners, as informed by statutory and ethical requirements.
A second key issue was the proper interpretation and application of Art 4.1.4 of the ECEG. Specifically, the court had to consider what it means for a treatment to be “generally accepted by the profession” and what evidential basis is required to show clinical justifiability. The case also raised the question of whether Dr Low’s approach could be characterised as part of a formal and approved clinical trial, which would be the only permissible context for offering remedies not generally accepted by the profession.
Finally, the case required the High Court to assess the evidential and reasoning basis of the DC’s findings. Appeals in professional disciplinary matters often turn on whether the DC made errors of law, whether its findings were supported by the evidence, and whether its conclusions were rationally reached. The High Court therefore had to examine whether the DC’s determination that five of seven charges were made out was justified on the record.
How Did the Court Analyse the Issues?
The High Court’s reasoning, as reflected in the extract, is anchored in the ethical framework that governs medical practice in Singapore. Art 4.1.4 of the ECEG is designed to protect patients by ensuring that doctors do not offer treatments that are not generally accepted by the profession unless they are conducted within a formal and approved clinical trial. The court treated this ethical requirement as a meaningful standard for assessing professional conduct, rather than as a mere guideline without practical consequences.
In applying Art 4.1.4, the court focused on the nature of the procedures at issue and the justification offered by Dr Low. Dr Low’s position, as seen from her correspondence, was that she had provided literature and that similar treatments were offered by other clinics and hospitals. She also relied on the existence of published studies and the apparent prevalence of the treatments in the market. The court’s analysis, however, required more than a superficial demonstration that “others do it” or that some studies exist. The ethical standard demands that the treatment be generally accepted and clinically justifiable for the relevant indications.
The court also considered the MOH’s and SMC’s concerns about the adequacy and relevance of the evidence provided. The MOH had indicated that much of the evidence Dr Low provided was either irrelevant or unsatisfactory, and that her response suggested she might be practising unsubstantiated practices beyond the specific list of procedures. The MOH further pointed to the clinic’s website content and media coverage as indicators that the procedures were still being offered for aesthetic purposes during the inquiry. These factors were relevant to whether Dr Low’s conduct aligned with the ethical requirement of not offering unaccepted remedies outside a clinical trial.
Another important aspect of the court’s analysis was the distinction between treatment and experimentation. Art 4.1.4 permits remedies not generally accepted by the profession only in the context of a formal and approved clinical trial, with appropriate ethics committee approval and compliance with Good Clinical Practice Guidelines, as well as informed consent. The court therefore examined whether Dr Low’s conduct could be properly characterised as clinical research conducted under those safeguards. On the facts as presented in the extract, the court was not persuaded that the procedures were conducted within an approved clinical trial framework. As a result, Dr Low could not rely on the “clinical trial” exception to justify offering treatments that were not shown to be generally accepted.
What Was the Outcome?
The High Court dismissed Dr Low’s appeal and upheld the DC’s decision convicting her of five out of seven charges. The practical effect of the decision is that Dr Low remained found to have engaged in professional misconduct in relation to the relevant aesthetic procedures, with the court affirming that the ethical standard in Art 4.1.4 was breached on the evidence before the DC.
While the extract does not reproduce the final orders on penalty, the outcome of the appeal confirms that the DC’s findings were legally and evidentially sound. For practitioners, the decision underscores that disciplinary outcomes will be sustained where the ethical and statutory requirements governing untested or insufficiently justified treatments are not met.
Why Does This Case Matter?
Low Chai Ling v Singapore Medical Council is significant because it illustrates how Singapore’s medical disciplinary framework operationalises patient protection through ethical codes. Art 4.1.4 of the ECEG is not treated as aspirational; rather, it provides a concrete benchmark for determining whether a doctor’s conduct is professionally acceptable. The case therefore serves as a reference point for how courts may evaluate claims that a treatment is justified because it is “widely practised” or supported by some literature.
For practitioners, the case highlights the evidential burden that may be expected when offering treatments that are potentially contentious or not clearly within generally accepted practice. Doctors should be prepared to demonstrate, with relevant and adequate evidence, that the treatment is generally accepted for the specific indications offered. Where a treatment is not generally accepted, the practitioner must ensure that the only permissible route is a properly approved clinical trial with ethics approval, Good Clinical Practice compliance, and informed consent.
From a compliance perspective, the case also demonstrates the importance of consistency between marketing materials, website content, and actual clinical practice. The MOH’s complaint relied partly on the persistence of listed services on the clinic’s website and on contemporaneous media reporting. This reinforces that disciplinary bodies may use external sources to test whether a practitioner’s representations to regulators align with real-world conduct.
Legislation Referenced
- Medical Registration Act (Cap 174, 1998 Rev Ed) — s 45(1)(d)
Cases Cited
- [2012] SGHC 191
Source Documents
This article analyses [2012] SGHC 191 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.